Individual- and Connectivity-Based Real-Time fMRI Neurofeedback to Modulate Emotion-Related Brain Responses in Patients with Depression: A Pilot Study.
NEO-FFI
Non-Responder
Responder
depression
dorsolateral prefrontal cortex
insula
real-time fMRI neurofeedback
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
14 Dec 2022
14 Dec 2022
Historique:
received:
15
11
2022
revised:
08
12
2022
accepted:
11
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Individual real-time functional magnetic resonance imaging neurofeedback (rtfMRI NF) might be a promising adjuvant in treating depressive symptoms. Further studies showed functional variations and connectivity-related changes in the dorsolateral prefrontal cortex (dlPFC) and the insular cortex. The aim of this pilot study was to investigate whether individualized connectivity-based rtfMRI NF training can improve symptoms in depressed patients as an adjunct to a psychotherapeutic programme. The novel strategy chosen for this was to increase connectivity between individualized regions of interest, namely the insula and the dlPFC. Sixteen patients diagnosed with major depressive disorder (MDD, ICD-10) and 19 matched healthy controls (HC) participated in a rtfMRI NF training consisting of two sessions with three runs each, within an interval of one week. RtfMRI NF was applied during a sequence of negative emotional pictures to modulate the connectivity between the dlPFC and the insula. The MDD REAL group was divided into a Responder and a Non-Responder group. Patients with an increased connectivity during the second NF session or during both the first and the second NF session were identified as "MDD REAL Responder" (N = 6). Patients that did not show any increase in connectivity and/or a decreased connectivity were identified as "MDD REAL Non-Responder" (N = 7). Before the rtfMRI sessions, patients with MDD showed higher neural activation levels in ventromedial PFC and the insula than HC; by contrast, HC revealed increased hemodynamic activity in visual processing areas (primary visual cortex and visual association cortex) compared to patients with MDD. The comparison of hemodynamic responses during the first compared to during the last NF session demonstrated significantly increased BOLD-activation in the medial orbitofrontal cortex (mOFC) in patients and HC, and additionally in the lateral OFC in patients with MDD. These findings were particularly due to the MDD Responder group, as the MDD Non-Responder group showed no increase in this region during the last NF run. There was a decrease of neural activation in emotional processing brain regions in both groups in the last NF run compared to the first: HC showed differences in the insula, parahippocampal gyrus, basal ganglia, and cingulate gyrus. Patients with MDD demonstrated deceased responses in the parahippocampal gyrus. There was no significant reduction of BDI scores after NF training in patients. Increased neural activation in the insula and vmPFC in MDD suggests an increased emotional reaction in patients with MDD. The activation of the mOFC could be associated with improved control-strategies and association-learning processes. The increased lOFC activation could indicate a stronger sensitivity to failed NF attempts in MDD. A stronger involvement of visual processing areas in HC may indicate better adaptation to negative emotional stimuli after repeated presentation. Overall, the rtfMRI NF had an impact on neurobiological mechanisms, but not on psychometric measures in patients with MDD.
Identifiants
pubmed: 36552173
pii: brainsci12121714
doi: 10.3390/brainsci12121714
pmc: PMC9775232
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ludwig Maximilian University, FöFoLe
ID : reck-nr: 902
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Biol Psychiatry. 2010 Jul 15;68(2):118-24
pubmed: 20303067
Biol Psychiatry. 2007 Sep 1;62(5):446-54
pubmed: 17217927
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2450-4
pubmed: 11842195
Am J Psychiatry. 2020 May 1;177(5):422-434
pubmed: 32098488
Prog Neurobiol. 2011 Apr;93(4):468-87
pubmed: 21349315
Trends Neurosci. 2006 Jun;29(6):317-22
pubmed: 16697058
Nat Rev Neurosci. 2017 Feb;18(2):86-100
pubmed: 28003656
Biol Psychiatry. 2000 Oct 15;48(8):830-43
pubmed: 11063978
Biol Psychiatry. 2019 Mar 1;85(5):379-388
pubmed: 30612699
Front Hum Neurosci. 2014 Apr 22;8:230
pubmed: 24795597
J Affect Disord. 2010 Apr;122(1-2):76-85
pubmed: 19589603
Behav Res Methods. 2019 Feb;51(1):195-203
pubmed: 30734206
Neuropsychopharmacology. 2018 Dec;43(13):2578-2585
pubmed: 29967368
J Cogn Neurosci. 2015 Aug;27(8):1552-72
pubmed: 25761006
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8582-8590
pubmed: 30962366
Am J Psychiatry. 2017 Aug 1;174(8):748-755
pubmed: 28407727
PLoS One. 2012;7(6):e38115
pubmed: 22675513
Front Psychiatry. 2018 Mar 15;9:83
pubmed: 29599728
PLoS One. 2014 Feb 11;9(2):e88785
pubmed: 24523939
Front Behav Neurosci. 2015 Jun 08;9:148
pubmed: 26106309
Psychiatry Res. 2009 May 15;172(2):99-102
pubmed: 19321317
J Affect Disord. 2008 Oct;110(3):197-206
pubmed: 18456340
J Neurosci Methods. 2007 Sep 15;165(1):144-50
pubmed: 17629569
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1487-92
pubmed: 17688985
Brain Sci. 2022 Aug 25;12(9):
pubmed: 36138864
J Affect Disord. 2013 Oct;151(1):178-85
pubmed: 23820093
J Neurosci. 2007 Jul 11;27(28):7498-507
pubmed: 17626211
Psychiatr Prax. 2004 Nov;31 Suppl 1:S70-2
pubmed: 15570508
Cochrane Database Syst Rev. 2019 May 20;5:CD012855
pubmed: 31106850
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
Front Hum Neurosci. 2019 Mar 04;13:65
pubmed: 30886575
Trends Cogn Sci. 2005 May;9(5):242-9
pubmed: 15866151
PLoS One. 2014 Jul 22;9(7):e102692
pubmed: 25051163
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Clin Psychol Rev. 2010 Feb;30(1):51-62
pubmed: 19781837
Biol Psychiatry. 2006 Aug 15;60(4):337-43
pubmed: 16712801
Hum Brain Mapp. 2011 Jan;32(1):22-31
pubmed: 21157877
Hum Brain Mapp. 2007 May;28(5):409-23
pubmed: 17133391
Biol Psychiatry. 2007 Jan 15;61(2):198-209
pubmed: 17027931
Neuroimage. 2014 Mar;88:113-24
pubmed: 24231399
J Affect Disord. 2020 Jun 15;271:224-227
pubmed: 32479320
Brain Struct Funct. 2010 Jun;214(5-6):519-34
pubmed: 20512376
J Consult Clin Psychol. 2009 Apr;77(2):367-71
pubmed: 19309197
Cereb Cortex. 2000 Mar;10(3):206-19
pubmed: 10731217
Nature. 1994 Jun 16;369(6481):525
pubmed: 8031403
Curr Opin Psychiatry. 2015 Jan;28(1):7-12
pubmed: 25415499
J Psychopharmacol. 2007 Jul;21(5):461-71
pubmed: 17050654
Prog Neurobiol. 2004 Apr;72(5):341-72
pubmed: 15157726
J Psychopharmacol. 2009 Sep;23(7):775-88
pubmed: 18635699
JAMA Psychiatry. 2020 Feb 1;77(2):172-179
pubmed: 31664439
Biol Psychiatry. 2001 Aug 1;50(3):171-8
pubmed: 11513815
BMC Psychiatry. 2012 Jun 13;12:61
pubmed: 22694751
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Neuroimage. 2010 Jan 1;49(1):1066-72
pubmed: 19646532
Mol Psychiatry. 2020 Jul;25(7):1511-1525
pubmed: 31471575
Neuroimage. 2003 Dec;20(4):2091-9
pubmed: 14683713
Psychother Psychosom. 2019;88(1):5-15
pubmed: 30699438
Neuroimage. 2007 Apr 15;35(3):1238-46
pubmed: 17336094
J Affect Disord. 2011 Sep;133(1-2):120-7
pubmed: 21531027
J Affect Disord. 2011 Apr;130(1-2):66-74
pubmed: 21030092
Br Med Bull. 2003;65:193-207
pubmed: 12697626
Neurosci Lett. 2016 Jun 3;623:71-8
pubmed: 27130821
Dialogues Clin Neurosci. 2014 Mar;16(1):75-81
pubmed: 24733972
JAMA Psychiatry. 2015 Jun;72(6):603-11
pubmed: 25785575
Biol Psychiatry. 2008 Sep 15;64(6):505-12
pubmed: 18550030
Neuron. 2005 Mar 3;45(5):651-60
pubmed: 15748841
Hum Brain Mapp. 2014 Mar;35(3):1061-73
pubmed: 23404748
PLoS One. 2015 Jul 23;10(7):e0133034
pubmed: 26204262
Biol Psychiatry. 2007 Sep 1;62(5):429-37
pubmed: 17210143
Am J Psychiatry. 2020 May 1;177(5):411-421
pubmed: 31964160
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jun;3(6):563-571
pubmed: 29550459
J Vis Exp. 2012 Jan 20;(59):
pubmed: 22297729
Neuroimage. 2020 Jul 1;214:116751
pubmed: 32194284
Brain Connect. 2014 Nov;4(9):690-701
pubmed: 25329241
J Affect Disord. 2017 Mar 01;210:303-311
pubmed: 28068619
Nat Rev Neurosci. 2009 Jan;10(1):59-70
pubmed: 19096369
Am J Psychiatry. 2003 May;160(5):990-2
pubmed: 12727705
Transl Psychiatry. 2022 Aug 27;12(1):349
pubmed: 36030219
Hum Brain Mapp. 2008 Jun;29(6):683-95
pubmed: 17598168
Neuron. 2004 Sep 16;43(6):897-905
pubmed: 15363399
Biol Psychiatry. 2003 Mar 15;53(6):502-10
pubmed: 12644355
J Affect Disord. 2008 Nov;111(1):13-20
pubmed: 18603301
Neuroimage. 2016 Jan 1;124(Pt A):214-223
pubmed: 26348555
Cogn Affect Behav Neurosci. 2010 Dec;10(4):470-8
pubmed: 21098808
Science. 1999 Mar 12;283(5408):1657-61
pubmed: 10073923
Curr Opin Neurobiol. 2010 Apr;20(2):231-5
pubmed: 20303254
J Comp Neurol. 2003 Jun 2;460(3):425-49
pubmed: 12692859
Behav Res Ther. 2014 Nov;62:120-8
pubmed: 25156399
Front Hum Neurosci. 2014 Jan 21;7:930
pubmed: 24478665
Neuroimage. 2003 Mar;18(3):760-8
pubmed: 12667853
Psychiatry Res. 2014 Dec;220 Suppl 1:S15-33
pubmed: 25539871
J Comp Neurol. 1995 Dec 25;363(4):615-641
pubmed: 8847421
Behav Brain Res. 2016 Sep 15;311:255-266
pubmed: 27235714
J Psychiatry Neurosci. 2006 Mar;31(2):101-4
pubmed: 16575425
Biol Psychiatry. 2017 Oct 15;82(8):578-586
pubmed: 28476207
Curr Neuropharmacol. 2015;13(4):466-79
pubmed: 26412066
Neurosci Lett. 2009 Dec 25;467(2):76-80
pubmed: 19818382
Front Hum Neurosci. 2020 Feb 25;14:60
pubmed: 32161529
Am J Psychiatry. 1995 Mar;152(3):341-51
pubmed: 7864258
Psychiatry Clin Neurosci. 2018 Jul;72(7):466-481
pubmed: 29687527
Neuroimage. 2018 May 15;172:786-807
pubmed: 29288868
Brain. 2012 May;135(Pt 5):1498-507
pubmed: 22418737
J Psychosom Res. 2002 Oct;53(4):849-57
pubmed: 12377293
Biol Psychiatry. 2008 Mar 15;63(6):577-86
pubmed: 17888411
J Cogn Neurosci. 2005 Oct;17(10):1509-18
pubmed: 16269093
Am J Psychiatry. 2012 Jul;169(7):693-703
pubmed: 22535198
Cereb Cortex. 2000 Mar;10(3):220-42
pubmed: 10731218
Neurosci Biobehav Rev. 2016 Sep;68:47-58
pubmed: 27181908
J Psychiatry Neurosci. 2017 Sep;42(5):343-352
pubmed: 28606245
Front Hum Neurosci. 2012 Dec 03;6:323
pubmed: 23227005
Behav Brain Res. 2009 Aug 12;201(2):239-43
pubmed: 19428640
Assessment. 2011 Mar;18(1):27-38
pubmed: 20881102